<html>
 <body>
  <div class="col-md-12" id="content" style="">
   <div class="hidden" data-drupal-messages-fallback="">
   </div>
   <div class="widget block" id="block-medsites-page-title">
    <h1>
     <span property="schema:name">
      Bacteremia
     </span>
    </h1>
   </div>
   <div class="widget block" id="block-medsites-content">
    <article about="/commodorecompendium/bacteremia" data-history-node-id="2557" role="article" typeof="schema:WebPage">
     <div>
      <div class="field field--name-body field--type-text-with-summary field--label-hidden field__item" property="schema:text">
       <div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 2.0pt 0in">
        <p style="border:none; padding:0in">
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <b>
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Bacteremia: Interpreting Verigene® Results – VASP
              </span>
             </span>
            </b>
           </span>
          </span>
         </span>
        </p>
       </div>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             <span style="color:black">
              Background
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li style="list-style-type:none">
         <ul>
          <li style="list-style-type:none">
           <ul>
            <li style="list-style-type:none">
             <ul>
              <li style="list-style-type:none">
               <ul>
                <li style="list-style-type:none">
                </li>
               </ul>
              </li>
             </ul>
            </li>
           </ul>
          </li>
         </ul>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                When BCx turn positive, the lab reports Gm stain and Verigene® results to help guide empiric therapy, while awaiting further species identification and susceptibilities.
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p style="margin-left:25px; text-indent:-9.35pt">
       </p>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             <span style="color:black">
              Management
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="color: black; font-family: Palatino; font-size: 12pt;">
          Start empiric antibiotic therapy (based on clinical picture and table below)
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Consider ordering repeat BCx x2 based on organism to document clearance
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
         <ul>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="background:white">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Repeat for: Staph (MRSA or MSSA), Strep lugdunensis
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
         </ul>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                If source control & no endovascular infxn,
                <b>
                 no need to repeat
                </b>
                (most other strep and GNR’s
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <a href="https://www.vumc.org/antimicrobial-stewardship-program/antibiograms">
              <span style="background:white">
               <span style="font-family:Palatino">
                VUMC antibiograms
               </span>
              </span>
             </a>
            </span>
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                can be used to reference typical resistance patterns and most common organisms in blood cultures.
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Consider clinical picture: Do you have a likely source of bacteremia? Do you need to consider/assess for additional sources of infection?
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Candida in
               </span>
              </span>
             </span>
            </span>
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                a blood culture is
                <b>
                 NEVER
                </b>
                considered a contaminant
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              Do not hesitate to consult Infectious Diseases (or page
              <b>
               615-317-GERM
              </b>
              ) with questions
              <a id="section-2" name="section-2">
              </a>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              Species identification and susceptibility is available in 2-3 days from positive culture
              <span id="cke_bm_236E" style="display: none;">
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p>
       </p>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             <b>
              GRAM POSITIVE COCCI
             </b>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <table align="center" class="TableGrid9" style="width:100.0%; border-collapse:collapse; border:none" width="100%">
        <table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>0</th>
      <th>1</th>
      <th>2</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Organism</td>
      <td>Resistance Marker</td>
      <td>Preliminary Recommendation</td>
    </tr>
    <tr>
      <td>Staphylococcus aureus or Staphylococcus lugdunensis</td>
      <td>mecA detected</td>
      <td>Start vancomycin IV</td>
    </tr>
    <tr>
      <td>Staphylococcus aureus or Staphylococcus lugdunensis</td>
      <td>No mecA detected</td>
      <td>Start nafcillin or cefazolin Stop empiric vancomycin IV</td>
    </tr>
    <tr>
      <td>Staphylococcus epidermidis - Often skin contaminant - Repeat cultures, start  therapy if uncertain</td>
      <td>mecA detected</td>
      <td>Start vancomycin IV</td>
    </tr>
    <tr>
      <td>Staphylococcus epidermidis - Often skin contaminant - Repeat cultures, start  therapy if uncertain</td>
      <td>No mecA detected</td>
      <td>Start nafcillin or cefazolin Stop empiric vancomycin IV</td>
    </tr>
    <tr>
      <td>Other coagulase negative Staph Often skin contaminant Repeat cultures start abx if uncertain</td>
      <td>NaN</td>
      <td>Start vancomycin IV</td>
    </tr>
    <tr>
      <td>Streptococcus: agalactiae, pyogenes, anginosus</td>
      <td>NaN</td>
      <td>Start penicillin IV Stop empiric vancomycin</td>
    </tr>
    <tr>
      <td>Streptococcus pneumoniae</td>
      <td>NaN</td>
      <td>Start ceftriaxone Stop empiric vancomycin Await PCN sensitivity data</td>
    </tr>
    <tr>
      <td>Other Streptococcus</td>
      <td>NaN</td>
      <td>Continue empiric vancomycin, awaiting susceptibilities</td>
    </tr>
    <tr>
      <td>Enterococcus faecalis</td>
      <td>vanA or vanB detected</td>
      <td>Start daptomycin 8-10mg/kg/day IV Don’t treat w vancomycin IV Contact precautions</td>
    </tr>
    <tr>
      <td>Enterococcus faecalis</td>
      <td>No vanA or vanB</td>
      <td>Start ampicillin Stop empiric vancomycin IV</td>
    </tr>
    <tr>
      <td>Enterococcus faecium</td>
      <td>vanA or vanB detected</td>
      <td>Start daptomycin 8-10mg/kg/day IV Don’t treat w vancomycin IV Contact precautions</td>
    </tr>
    <tr>
      <td>Enterococcus faecium</td>
      <td>No vanA or vanB</td>
      <td>Start vancomycin IV</td>
    </tr>
  </tbody>
</table>
       </table>
       <p>
       </p>
       <p>
       </p>
       <p>
       </p>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:7.0pt">
          <span style="font-family:Calibri,sans-serif">
           <b>
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              GRAM POSITIVE RODS
             </span>
            </span>
           </b>
          </span>
         </span>
        </span>
       </p>
       <table align="center" class="TableGrid9" style="width:100.0%; border-collapse:collapse; border:none" width="100%">
        <table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>0</th>
      <th>1</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Organism</td>
      <td>Preliminary Recommendation</td>
    </tr>
    <tr>
      <td>Listeria monocytogenes</td>
      <td>Start ampicillin Stop empiric vancomycin IV</td>
    </tr>
    <tr>
      <td>Other Gram positive rod Often skin contaminant Repeat cultures, start therapy if uncertain</td>
      <td>Start vancomycin IV</td>
    </tr>
  </tbody>
</table>
       </table>
       <p>
       </p>
       <p>
       </p>
       <p>
       </p>
       <p>
       </p>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:7.0pt">
          <span style="font-family:Calibri,sans-serif">
           <b>
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              GRAM NEGATIVE RODS *Consult ID if carbapenem resistance detected*
             </span>
            </span>
           </b>
          </span>
         </span>
        </span>
       </p>
       <table align="center" class="TableGrid9" style="width:100.0%; border-collapse:collapse; border:none" width="100%">
        <table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>Organism</th>
      <th>Resistance Marker</th>
      <th>Preliminary Recommendation</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Acinetobacter species</td>
      <td>None</td>
      <td>Start IV meropenem 1g q8h IV until sensitivities available</td>
    </tr>
    <tr>
      <td>Acinetobacter species</td>
      <td>ESBL (CTX-M)</td>
      <td>Start meropenem 1g q8h IV Consider ID consult Contact precautions</td>
    </tr>
    <tr>
      <td>Acinetobacter species</td>
      <td>carbapenem resistance</td>
      <td>Consult Infectious Diseases Contact precautions</td>
    </tr>
    <tr>
      <td>Citrobacter or Serratia species</td>
      <td>None</td>
      <td>Start cefepime 2g q8h IV</td>
    </tr>
    <tr>
      <td>Citrobacter or Serratia species</td>
      <td>ESBL (CTX-M)</td>
      <td>Start carbapenem therapy contact precautions</td>
    </tr>
    <tr>
      <td>Citrobacter or Serratia species</td>
      <td>carbapenem resistance</td>
      <td>Consult Infectious Diseases Contact precautions</td>
    </tr>
    <tr>
      <td>Enterobacter species</td>
      <td>None</td>
      <td>Start cefepime 2g q8h IV</td>
    </tr>
    <tr>
      <td>Enterobacter species</td>
      <td>ESBL (CTX-M)</td>
      <td>Start carbapenem therapy contact precautions</td>
    </tr>
    <tr>
      <td>Enterobacter species</td>
      <td>carbapenem resistance</td>
      <td>Consult Infectious Diseases Contact precautions</td>
    </tr>
    <tr>
      <td>Escherichia coli</td>
      <td>None</td>
      <td>Start IV ceftriaxone 2g q24h IV</td>
    </tr>
    <tr>
      <td>Escherichia coli</td>
      <td>ESBL (CTX-M)</td>
      <td>Start carbapenem therapy Contact precautions</td>
    </tr>
    <tr>
      <td>Escherichia coli</td>
      <td>carbapenem resistance</td>
      <td>Consult Infectious Diseases Contact precautions</td>
    </tr>
    <tr>
      <td>Klebsiella pneumoniae or oxytoca</td>
      <td>None</td>
      <td>Start ceftriaxone 2g q24h IV</td>
    </tr>
    <tr>
      <td>Klebsiella pneumoniae or oxytoca</td>
      <td>ESBL (CTX-M)</td>
      <td>Start carbapenem therapy Contact precautions</td>
    </tr>
    <tr>
      <td>Klebsiella pneumoniae or oxytoca</td>
      <td>carbapenem resistance</td>
      <td>Consult Infectious Diseases Contact precautions</td>
    </tr>
    <tr>
      <td>Proteus species</td>
      <td>None</td>
      <td>Start ceftriaxone 2g q24h IV</td>
    </tr>
    <tr>
      <td>Proteus species</td>
      <td>ESBL (CTX-M)</td>
      <td>Start carbapenem therapy Contact precautions</td>
    </tr>
    <tr>
      <td>Proteus species</td>
      <td>carbapenem resistance</td>
      <td>Consult Infectious Diseases Contact precautions</td>
    </tr>
    <tr>
      <td>Pseudomonas aeruginosa</td>
      <td>None</td>
      <td>Start IV cefepime 2g q8h IV</td>
    </tr>
    <tr>
      <td>Pseudomonas aeruginosa</td>
      <td>ESBL (CTX-M)</td>
      <td>Start meropenem (do not start ertapenem) Contact precautions</td>
    </tr>
    <tr>
      <td>Pseudomonas aeruginosa</td>
      <td>carbapenem resistance</td>
      <td>Consult Infectious Diseases Contact precautions</td>
    </tr>
  </tbody>
</table>
       </table>
      </div>
     </div>
    </article>
   </div>
  </div>
 </body>
</html>